Drug · DIN 02468336
PROPOFOL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since January 30, 2024; first marketed April 24, 2018.
- Drug Identification Number (DIN)
- 02468336
- Company (DIN owner)
- Baxter CorporationMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Emulsion
- Route
- Intravenous
- Therapeutic class (ATC)
- Propofol N01AX10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PROPOFOL | 10 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 29, 2017: NOC 19861Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies